---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-000514"
form_type: "8-K"
ticker: "SGHT"
cik: "0001531177"
company_name: "Sight Sciences, Inc."
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T17:48:05.449971+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sight Sciences reports preliminary Q4 2022 revenue ~$20.5M, up 40% YoY; CFO Selnick steps down, Rodberg interim

## Summary
- Preliminary Q4 2022 total revenue $20.4M-$20.6M (+40% YoY); full-year revenue $71.2M-$71.4M (+46% YoY).
- Surgical Glaucoma revenue Q4 $18.7M-$18.8M (+35% YoY); Dry Eye revenue $1.7M-$1.8M (+130% YoY).
- CFO Jesse Selnick stepped down effective Jan 9, 2023; will provide transition consulting. Jim Rodberg appointed interim CFO.
- Director Mack Hicks resigned from Board and Audit Committee; Dr. Tamara Fountain appointed to Audit Committee.
- Company expects to announce complete Q4 and FY2022 results in March 2023; results are preliminary and subject to audit.

## SEC filing metadata
- accession: 0000950170-23-000514
- form_type: 8-K
- ticker: SGHT
- cik: 0001531177
- company_name: Sight Sciences, Inc.
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1531177/000095017023000514/0000950170-23-000514-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1531177/000095017023000514/sght-20230105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-000514
- JSON: https://secwatch.observer/filing/0000950170-23-000514.json
- Plain text: https://secwatch.observer/filing/0000950170-23-000514.txt

## Key facts
- Earnings Releases
  Sight Sciences, Inc. reported the fourth quarter and year ended December 31, 2022 results: revenue $20.4 million to $20.6 million (Q4), $71.2 million to $71.4 million (full year).
  - Period: the fourth quarter and year ended December 31, 2022
  - Revenue: $20.4 million to $20.6 million (Q4), $71.2 million to $71.4 million (full year)
  - Result: preliminary results
  source text: announcing preliminary unaudited financial results for the fourth quarter and year ended December 31, 2022. Fourth quarter 2022 total revenue is expected to be in the range of $20.4 million to $20.6 million, an increase of 40% compared to the prior year period and a sequential increase of 10% compared to the third quarter of 2022 at the estimated midpoint. •
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531177/000095017023000514/0000950170-23-000514-index.htm
- Executive change
  Mack Hicks departed as Director at Sight Sciences, Inc..
  - Action: stepped down
  - Role: Director
  source text: Effective January 5, 2023, Mack Hicks stepped down as a Class II director and as a member of the Audit Committee of the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531177/000095017023000514/0000950170-23-000514-index.htm
- Executive change
  Jesse Selnick departed as Chief Financial Officer and Treasurer at Sight Sciences, Inc..
  - Action: stepped down
  - Role: Chief Financial Officer and Treasurer
  source text: Effective January 9, 2023, Jesse Selnick, the Company’s Chief Financial Officer and Treasurer, stepped down from his positions with the Company effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531177/000095017023000514/0000950170-23-000514-index.htm
- Executive change
  Jim Rodberg was appointed as Interim Chief Financial Officer and Treasurer at Sight Sciences, Inc..
  - Action: appointed
  - Role: Interim Chief Financial Officer and Treasurer
  source text: Effective January 9, 2023, Jim Rodberg, the Company’s Vice President of Finance and Corporate Controller, was appointed by the Board of Directors of the Company (the “Board”) to serve as interim Chief Financial Officer and Treasurer until the appointment of Mr. Selnick’s successor.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531177/000095017023000514/0000950170-23-000514-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.